Clinical Trial Update: Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of indacaterol acetate delivered via Concept1 inhalation device in children aged 6 to <12 with asthma; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• indacaterol (acetate) (indacaterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27